| Year |
Citation |
Score |
| 2017 |
Marketou M, Spanaki A, Kontaraki J, Parthenakis F, Tsiverdis P, Konstantinou J, Vougia D, Logakis J, Gavras I, Gavras H, Vardas P. [Pp.30.10] Increased Alpha2B-Adrenergic Receptors Gene Expression In Platelets From Patients With Not Adequately Controlled Essential Hypertension Journal of Hypertension. 35. DOI: 10.1097/01.Hjh.0000523990.19919.57 |
0.378 |
|
| 2014 |
Marketou ME, Kontaraki J, Zacharis E, Parthenakis F, Maragkoudakis S, Gavras I, Gavras H, Vardas PE. Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertension. Journal of Human Hypertension. 28: 450-455. PMID 24401952 DOI: 10.1038/Jhh.2013.133 |
0.355 |
|
| 2012 |
Gavras I, Gavras H. 'Volume-expanded' hypertension: the effect of fluid overload and the role of the sympathetic nervous system in salt-dependent hypertension. Journal of Hypertension. 30: 655-9. PMID 22227820 DOI: 10.1097/Hjh.0B013E32834F6De1 |
0.413 |
|
| 2012 |
Koupenova M, Johnston-Cox H, Vezeridis A, Gavras H, Yang D, Zannis V, Ravid K. A2b adenosine receptor regulates hyperlipidemia and atherosclerosis. Circulation. 125: 354-63. PMID 22144568 DOI: 10.1161/Circulationaha.111.057596 |
0.308 |
|
| 2011 |
Marketou M, Kontaraki J, Zacharis E, Kochiadakis G, Gavras I, Gavras H, Vardas P. Upregulation Of Gene Expression Of Bradykinin Receptors Type 1 And 2 In Peripheral Monocytes In Patients With Essential Hypertension: Pp.20.148 Journal of Hypertension. 29. DOI: 10.1097/00004872-201106001-00972 |
0.383 |
|
| 2011 |
Marketou M, Kontaraki J, Zacharis E, Kochiadakis G, Gavras H, Gavras I, Vardas P. Upregulation Of Bradykinin Receptors 1 And 2 Gene Transcript Levels In Peripheral Monocytes In Patients With Essential Hypertension Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)60530-5 |
0.384 |
|
| 2010 |
Manolis AJ, Marketou ME, Gavras I, Gavras H. Cardioprotective properties of bradykinin: role of the B(2) receptor. Hypertension Research : Official Journal of the Japanese Society of Hypertension. 33: 772-7. PMID 20505673 DOI: 10.1038/Hr.2010.82 |
0.346 |
|
| 2010 |
Marketou M, Kintsurashvili E, Papanicolaou KN, Lucero HA, Gavras I, Gavras H. Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct. American Journal of Hypertension. 23: 562-8. PMID 20186129 DOI: 10.1038/Ajh.2010.20 |
0.314 |
|
| 2010 |
McCalmon SA, Desjardins DM, Ahmad S, Davidoff KS, Snyder CM, Sato K, Ohashi K, Kielbasa OM, Mathew M, Ewen EP, Walsh K, Gavras H, Naya FJ. Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2. Circulation Research. 106: 952-60. PMID 20093629 DOI: 10.1161/Circresaha.109.209007 |
0.311 |
|
| 2010 |
Lucero HA, Kintsurashvili E, Marketou ME, Gavras H. Cell signaling, internalization, and nuclear localization of the angiotensin converting enzyme in smooth muscle and endothelial cells. The Journal of Biological Chemistry. 285: 5555-68. PMID 20022959 DOI: 10.1074/Jbc.M109.074740 |
0.334 |
|
| 2010 |
Gavras H. New Developments in the Field of RAS Inhibition Hospital Chronicles. 5: 178-179. DOI: 10.2015/Hc.V5I1 |
0.391 |
|
| 2009 |
Ahmad S, Cesana F, Lamperti E, Gavras H, Yu J. Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant. American Journal of Hypertension. 22: 1320-5. PMID 19779471 DOI: 10.1038/Ajh.2009.181 |
0.393 |
|
| 2009 |
Kintsurashvili E, Shenouda S, Ona D, Ona L, Ahmad S, Ravid K, Gavras I, Gavras H. Hypertension in transgenic mice with brain-selective overexpression of the alpha(2B)-adrenoceptor. American Journal of Hypertension. 22: 41-5. PMID 18989257 DOI: 10.1038/Ajh.2008.314 |
0.74 |
|
| 2009 |
Gavras H. Pathogenesis of Hypertension: A Review Hamdan Medical Journal. 2: 25-28. DOI: 10.2174/1996327000902010025 |
0.353 |
|
| 2008 |
Duka A, Kintsurashvili E, Duka I, Ona D, Hopkins TA, Bader M, Gavras I, Gavras H. Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors. Hypertension. 51: 1352-7. PMID 18347228 DOI: 10.1161/Hypertensionaha.107.108506 |
0.329 |
|
| 2008 |
Gavras H. The Role of Double Renin-Angiotensin System Blockade Hospital Chronicles. 3: 100-101. DOI: 10.2015/Hc.V4I3.330 |
0.386 |
|
| 2008 |
Gavras H. Fixed Combinations in Antihypertensive Therapy Hospital Chronicles. 3: 208-209. DOI: 10.2015/Hc.V4I1.313 |
0.317 |
|
| 2007 |
Gavras H, Brunner HR. Evolution and hypertension: is the Renin system necessary? Hypertension. 49: e36; author reply e3. PMID 17389253 DOI: 10.1161/Hypertensionaha.107.088963 |
0.378 |
|
| 2007 |
Sun B, Kintsurashvili E, Ona D, Ignjacev-Lazich I, Gavras I, Gavras H. Inhibition of the alpha(1D)-adrenergic receptor gene by RNA interference (RNAi) in rat vascular smooth muscle cells and its effects on other adrenergic receptors. Vascular Pharmacology. 46: 367-72. PMID 17307398 DOI: 10.1016/J.Vph.2007.01.002 |
0.309 |
|
| 2006 |
Shenouda SM, Johns C, Kintsurashvili E, Gavras I, Gavras H. Long-term inhibition of the central alpha(2B)-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive rats. American Journal of Hypertension. 19: 1135-43. PMID 17070424 DOI: 10.1016/J.Amjhyper.2006.04.001 |
0.767 |
|
| 2006 |
Triantafyllidi H, Kintsurashvili E, Johns C, Gavras I, Gavras H. Central plasmid antisense administration reduces blood pressure inhibiting alpha2B adrenoceptor gene expression in spontaneously hypertensive rats in vivo. Hellenic Journal of Cardiology : Hjc = HellēNikē Kardiologikē EpitheōRēSĒ. 47: 144-9. PMID 16862820 |
0.329 |
|
| 2006 |
Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. The Journal of Clinical Investigation. 116: 1913-23. PMID 16823489 DOI: 10.1172/Jci27933 |
0.308 |
|
| 2006 |
Duka A, Duka I, Gao G, Shenouda S, Gavras I, Gavras H. Role of bradykinin B1 and B2 receptors in normal blood pressure regulation. American Journal of Physiology. Endocrinology and Metabolism. 291: E268-74. PMID 16507603 DOI: 10.1152/Ajpendo.00382.2005 |
0.769 |
|
| 2006 |
Duka A, Schwartz F, Duka I, Johns C, Melista E, Gavras I, Gavras H. A novel gene (Cmya3) induced in the heart by angiotensin II-dependent but not salt-dependent hypertension in mice. American Journal of Hypertension. 19: 275-81. PMID 16500513 DOI: 10.1016/J.Amjhyper.2005.08.017 |
0.375 |
|
| 2006 |
Gavras H. Role of Angiotensin and its Inhibition in Hypertension, Ischemic Heart Disease and Heart Failure Hospital Chronicles. 1: 100-101. DOI: 10.2015/Hc.V3I3.273 |
0.416 |
|
| 2005 |
Ignjacev-Lazich I, Kintsurashvili E, Johns C, Vitseva O, Duka A, Shenouda S, Gavras I, Gavras H. Angiotensin-converting enzyme regulates bradykinin receptor gene expression. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1814-20. PMID 16219810 DOI: 10.1016/J.Amjhyper.2004.03.014 |
0.757 |
|
| 2005 |
Russo CJ, Melista E, Cui J, DeStefano AL, Bakris GL, Manolis AJ, Gavras H, Baldwin CT. Association of NEDD4L ubiquitin ligase with essential hypertension. Hypertension. 46: 488-91. PMID 16103266 DOI: 10.1161/01.Hyp.0000178594.63193.C0 |
0.378 |
|
| 2005 |
Zhou XF, Cui J, DeStefano AL, Chazaro I, Farrer LA, Manolis AJ, Gavras H, Baldwin CT. Polymorphisms in the promoter region of catalase gene and essential hypertension. Disease Markers. 21: 3-7. PMID 15735318 DOI: 10.1155/2005/487014 |
0.31 |
|
| 2005 |
Kintsurashvili E, Duka A, Ignjacev I, Pattakos G, Gavras I, Gavras H. Age-related changes of bradykinin B1 and B2 receptors in rat heart. American Journal of Physiology. Heart and Circulatory Physiology. 289: H202-5. PMID 15708952 DOI: 10.1152/Ajpheart.01287.2004 |
0.339 |
|
| 2005 |
Manolis AJ, Iraklianou S, Pittaras A, Zaris M, Tsioufis K, Psaltiras G, Psomali D, Foussas S, Gavras I, Gavras H. Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy. American Journal of Hypertension. 18: 18-22. PMID 15691612 DOI: 10.1016/J.Amjhyper.2004.08.014 |
0.317 |
|
| 2005 |
Gavras H. Report on the fifth annual Laragh conference: Interaction of the angiotensin converting enzyme (ACE) with the renin-angiotensin system, the kinin system and beyond. American Journal of Hypertension. 18: 1-2. PMID 15691609 DOI: 10.1016/J.Amjhyper.2004.08.015 |
0.33 |
|
| 2005 |
Cui J, Melista E, Chazaro I, Zhang Y, Zhou X, Manolis AJ, Baldwin CT, Destefano AL, Gavras H. Sequence variation of bradykinin receptors B1 and B2 and association with hypertension. Journal of Hypertension. 23: 55-62. PMID 15643125 DOI: 10.1097/00004872-200501000-00013 |
0.34 |
|
| 2005 |
Alderman MH, Banes J, Blumenfeld JD, Gavras H, Kurtz T, Laragh JH, Steiner S. The american journal of hypertension withdraws from its affiliation with the american society of hypertension. A report to our readers American Journal of Hypertension. 18: 893-893. DOI: 10.1016/J.Amjhyper.2005.06.003 |
0.324 |
|
| 2004 |
Martin LC, Franco RJ, Gavras I, Matsubara BB, Garcia S, Caramori JT, Barretti BB, Balbi AL, Barsanti R, Padovani C, Gavras H. Association between hypervolemia and ventricular hypertrophy in hemodialysis patients. American Journal of Hypertension. 17: 1163-9. PMID 15607624 DOI: 10.1016/J.Amjhyper.2004.07.017 |
0.314 |
|
| 2004 |
Schwartz F, Duka A, Duka I, Cui J, Gavras H. Novel targets of ANG II regulation in mouse heart identified by serial analysis of gene expression. American Journal of Physiology. Heart and Circulatory Physiology. 287: H1957-66. PMID 15242839 DOI: 10.1152/Ajpheart.00568.2004 |
0.321 |
|
| 2004 |
Elijovich F, Laffer CL, Schiffrin EL, Gavras H, Amador E. Endothelin-aldosterone interaction and proteinuria in low-renin hypertension. Journal of Hypertension. 22: 573-82. PMID 15076164 DOI: 10.1097/00004872-200403000-00021 |
0.39 |
|
| 2004 |
DiPetrillo K, Tsaih SW, Sheehan S, Johns C, Kelmenson P, Gavras H, Churchill GA, Paigen B. Genetic analysis of blood pressure in C3H/HeJ and SWR/J mice Physiological Genomics. 17: 215-220. PMID 14996992 DOI: 10.1152/Physiolgenomics.00212.2003 |
0.308 |
|
| 2004 |
Gavras H. Adrenergic receptors in hypertension and heart failure. American Journal of Hypertension. 17: 98-9. PMID 14700521 DOI: 10.1016/J.Amjhyper.2003.08.011 |
0.357 |
|
| 2004 |
Elijovich F, Laffer CL, Amador E, Gavras H, Bresnahan MR, Schiffrin EL. Regulation of plasma endothelin by salt in salt-sensitive hypertension. Circulation. 103: 263-8. PMID 11208687 DOI: 10.1161/01.Cir.103.2.263 |
0.404 |
|
| 2004 |
Gavras H, Cui J, Zhou X, Chazaro I, DeSefano A, Manolis A, Baldwin C. Association Of Polymorphisms In The Promoter Region Of The Pnmt Gene With Essential Hypertension In African Americans But Not In Whites: P 642 Journal of Hypertension. 22. DOI: 10.1097/00004872-200402001-00761 |
0.305 |
|
| 2003 |
Schwartz F, Duka A, Triantafyllidi E, Johns C, Duka I, Cui J, Gavras H. Serial analysis of gene expression in mouse kidney following angiotensin II administration. Physiological Genomics. 16: 90-8. PMID 14570981 DOI: 10.1152/Physiolgenomics.00108.2003 |
0.381 |
|
| 2003 |
Duka I, Duka A, Kintsurashvili E, Johns C, Gavras I, Gavras H. Mechanisms mediating the vasoactive effects of the B1 receptors of bradykinin. Hypertension. 42: 1021-5. PMID 14557281 DOI: 10.1161/01.Hyp.0000097550.98865.35 |
0.411 |
|
| 2003 |
Cui J, Zhou X, Chazaro I, DeStefano AL, Manolis AJ, Baldwin CT, Gavras H. Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites. American Journal of Hypertension. 16: 859-63. PMID 14553966 DOI: 10.1016/S0895-7061(03)01026-4 |
0.35 |
|
| 2003 |
Erlich PM, Cui J, Chazaro I, Farrer LA, Baldwin CT, Gavras H, DeStefano AL. Genetic variants of WNK4 in whites and African Americans with hypertension. Hypertension. 41: 1191-5. PMID 12719438 DOI: 10.1161/01.Hyp.0000070025.30572.91 |
0.342 |
|
| 2003 |
Kintsurashvili E, Johns C, Ignjacev I, Gavras I, Gavras H. Central alpha2B-adrenergic receptor antisense in plasmid vector prolongs reversal of salt-dependent hypertension. Journal of Hypertension. 21: 961-7. PMID 12714871 DOI: 10.1097/00004872-200305000-00021 |
0.424 |
|
| 2003 |
Gavras H, Gavras I. Angioedema and AT1 Receptor Blockers: Proceed With Caution—Reply Jama Internal Medicine. 163: 1489-1489. DOI: 10.1001/Archinte.163.12.1488-A |
0.304 |
|
| 2002 |
Gavras I, Gavras H. Angiotensin II as a cardiovascular risk factor Journal of Human Hypertension. 16. PMID 11967726 DOI: 10.1038/Sj.Jhh.1001392 |
0.357 |
|
| 2002 |
Brunner HR, Gavras H. Angiotensin blockade for hypertension: a promise fulfilled. Lancet (London, England). 359: 990-2. PMID 11937175 DOI: 10.1016/S0140-6736(02)08062-5 |
0.428 |
|
| 2002 |
Gavras I, Gavras H. Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykinin Current Opinion in Endocrinology & Diabetes. 9: 323-328. DOI: 10.1097/00060793-200208000-00005 |
0.309 |
|
| 2002 |
Kintsurashvili E, Johns C, Ignjacev I, Gavras I, Gavras H. P-348: Reversal of salt-induced hypertension by translational inhibition of the alpha2B-adrenergic receptor (AR) American Journal of Hypertension. 15. DOI: 10.1016/S0895-7061(02)02699-7 |
0.379 |
|
| 2001 |
Gavras I, Gavras H. Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? Current Controlled Trials in Cardiovascular Medicine. 2: 257-259. PMID 11806808 DOI: 10.1186/Cvm-2-6-257 |
0.397 |
|
| 2001 |
Duka I, Shenouda S, Johns C, Kintsurashvili E, Gavras I, Gavras H. Role of the B2 Receptor of Bradykinin in Insulin Sensitivity Hypertension. 38: 1355-1360. PMID 11751717 DOI: 10.1161/Hy1201.096574 |
0.734 |
|
| 2001 |
Gavras I, Manolis AJ, Gavras H. The α2-adrenergic receptors in hypertension and heart failure: experimental and clinical studies Journal of Hypertension. 19: 2115-2124. PMID 11725152 DOI: 10.1097/00004872-200112000-00001 |
0.33 |
|
| 2001 |
Kintsurashvili E, Gavras I, Johns C, Gavras H. Effects of Antisense Oligodeoxynucleotide Targeting of the α2B-Adrenergic Receptor Messenger RNA in the Central Nervous System Hypertension. 38: 1075-1080. PMID 11711500 DOI: 10.1161/Hy1101.093426 |
0.387 |
|
| 2001 |
Kintsurashvili E, Duka I, Gavras I, Johns C, Farmakiotis D, Gavras H. Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 281. PMID 11557571 DOI: 10.1152/Ajpheart.2001.281.4.H1778 |
0.35 |
|
| 2001 |
Stefanadis C, Manolis A, Dernellis J, Tsioufis C, Tsiamis E, Gavras I, Gavras H, Toutouzas P. Acute effect of clonidine on left ventricular pressure-volume relation in hypertensive patients with diastolic heart dysfunction. Journal of Human Hypertension. 15: 635-642. PMID 11550110 DOI: 10.1038/Sj.Jhh.1001243 |
0.364 |
|
| 2001 |
Gavras I, Gavras H. Role of α2-adrenergic receptors in hypertension* American Journal of Hypertension. 14. PMID 11411753 DOI: 10.1016/S0895-7061(01)02085-4 |
0.316 |
|
| 2001 |
Gavras H, Brunner HR. Role of Angiotensin and Its Inhibition in Hypertension, Ischemic Heart Disease, and Heart Failure Hypertension. 37: 342-345. PMID 11230297 DOI: 10.1161/01.Hyp.37.2.342 |
0.369 |
|
| 2001 |
Duka I, Kintsurashvili E, Gavras I, Johns C, Bresnahan M, Gavras H. Vasoactive Potential of the B1 Bradykinin Receptor in Normotension and Hypertension Circulation Research. 88: 275-281. PMID 11179194 DOI: 10.1161/01.Res.88.3.275 |
0.376 |
|
| 2001 |
Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics. 71: 70-7. PMID 11161799 DOI: 10.1006/Geno.2000.6401 |
0.364 |
|
| 2001 |
Manolis AJ, Psomali D, Pittaras A, Loukatzikou A, Beldekos D, Karagianni E, Foussas S, Bresnahan MR, Gavras I, Gavras H. P-220: Comparison of diltiazem-SR vs amlodipine on resting and stimulated blood pressure, catecholamines and diastolic dysfunction in patients with mild to moderate essential hypertension American Journal of Hypertension. 14. DOI: 10.1016/S0895-7061(01)01410-8 |
0.396 |
|
| 2000 |
Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension. 36: 477-83. PMID 11040222 DOI: 10.1161/01.Hyp.36.4.477 |
0.361 |
|
| 2000 |
Duka I, Gavras I, Johns C, Handy DE, Gavras H. Role of the postsynaptic α2-adrenergic receptor subtypes in catecholamine-induced vasoconstriction General Pharmacology-the Vascular System. 34: 101-106. PMID 10974417 DOI: 10.1016/S0306-3623(00)00051-3 |
0.313 |
|
| 2000 |
Gavras I, Gavras H. The antiarrhythmic potential of angiotensin II antagonism: experience with losartan. American Journal of Hypertension. 13: 512-517. PMID 10826402 DOI: 10.1016/S0895-7061(99)00277-0 |
0.361 |
|
| 2000 |
Zhao Z, Makaritsis K, Francis CE, Gavras H, Ravid K. A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: Studies in knock-out mice Biochimica Et Biophysica Acta - Molecular Basis of Disease. 1500: 280-290. PMID 10699369 DOI: 10.1016/S0925-4439(99)00111-8 |
0.351 |
|
| 2000 |
Makaritsis KP, Johns C, Gavras I, Gavras H. Role of α2-Adrenergic Receptor Subtypes in the Acute Hypertensive Response to Hypertonic Saline Infusion in Anephric Mice Hypertension. 35: 609-613. PMID 10679505 DOI: 10.1161/01.Hyp.35.2.609 |
0.356 |
|
| 2000 |
Duka I, Johns C, Gavras I, Bresnahan MR, Gavras H. Role of the Bradykinin B2 Receptor in Salt-Induced Hypertension Hypertension. 36: 727-727. DOI: 10.1161/01.Hyp.36.Suppl_1.727-C |
0.444 |
|
| 2000 |
DeStefano AL, Gavras H, Heard N, Bursztyn M, Manolis A, Farrer LA, Baldwin CT, Gavras I, Schwartz F. Maternal Influence on the Inheritance of Hypertension Hypertension. 36: 718-718. DOI: 10.1161/01.Hyp.36.Suppl_1.718-A |
0.338 |
|
| 2000 |
Gavras H. Saturdy, may 20, broadway ballroom north, 6:30 am to 8:00 am. improvement in clinical outcomes in hypertension: Advantages of angiotensin receptor blockers: Issues in hypertension: Drug tolerability and special populations American Journal of Hypertension. 13. DOI: 10.1016/S0895-7061(00)00889-X |
0.365 |
|
| 1999 |
Baldwin CT, Schwartz F, Baima J, Burzstyn M, DeStefano AL, Gavras I, Handy DE, Joost O, Martel T, Manolis A, Nicolaou M, Bresnahan M, Farrer L, Gavras H. Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension. American Journal of Hypertension. 12: 853-7. PMID 10509541 DOI: 10.1016/S0895-7061(99)00070-9 |
0.394 |
|
| 1999 |
Makaritsis KP, Johns C, Gavras I, Altman JD, Handy DE, Bresnahan MR, Gavras H. Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype. Hypertension. 34: 403-7. PMID 10489385 DOI: 10.1161/01.Hyp.34.3.403 |
0.328 |
|
| 1999 |
Baima J, Nicolaou M, Schwartz F, DeStefano AL, Manolis A, Gavras I, Laffer C, Elijovich F, Farrer L, Baldwin CT, Gavras H. Evidence for Linkage Between Essential Hypertension and a Putative Locus on Human Chromosome 17 Hypertension. 34: 4-7. PMID 10406815 DOI: 10.1161/01.Hyp.34.1.4 |
0.334 |
|
| 1999 |
Gavras I, Manolis A, Gavras H. Genetic epidemiology of essential hypertension. Journal of Human Hypertension. 13: 225-229. PMID 10333339 DOI: 10.1038/Sj.Jhh.1000794 |
0.329 |
|
| 1999 |
Gavras I, Gavras H. Effects of Eprosartan Versus Enalapril in Hypertensive Patients on the Renin-Angiotensin-Aldosterone System and Safety Parameters: Results from a 26-Week, Double-blind, Multicentre Study Current Medical Research and Opinion. 15: 15-24. PMID 10216807 DOI: 10.1185/03007999909115169 |
0.362 |
|
| 1999 |
Makaritsis KP, Handy DE, Johns C, Kobilka B, Gavras I, Gavras H. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension (Dallas, Tex. : 1979). 33: 14-7. PMID 9931075 DOI: 10.1161/01.Hyp.33.1.14 |
0.402 |
|
| 1998 |
Makaritsis KP, Gavras H, Du Y, Chobanian AV, Brecher P. α1-Adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E-deficient mice Hypertension. 32: 1044-1048. PMID 9856971 DOI: 10.1161/01.Hyp.32.6.1044 |
0.403 |
|
| 1998 |
Balbi AL, Franco RJS, Barretti P, Gavras I, Gavras H. Renal artery clipping attenuates the progression of adriamycin nephropathy. American Journal of Hypertension. 11: 1124-1128. PMID 9752899 DOI: 10.1016/S0895-7061(98)00119-8 |
0.322 |
|
| 1998 |
Manolis AJ, Beldekos D, Handanis S, Haralabidis G, Hatzissavas J, Foussas S, Cokkinos DV, Bresnahan M, Gavras I, Gavras H. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity. American Journal of Hypertension. 11: 640-648. PMID 9657622 DOI: 10.1016/S0895-7061(98)00036-3 |
0.41 |
|
| 1998 |
Gavras H. Role of the renin angiotensin system and the sympathetic nervous system in the heart American Journal of Hypertension. 11: 2-4. DOI: 10.1016/S0895-7061(97)91613-7 |
0.32 |
|
| 1997 |
Manolis AJ, Beldekos D, Hatzissavas J, Foussas S, Cokkinos D, Bresnahan M, Gavras I, Gavras H. Hemodynamic and Humoral Correlates in Essential Hypertension Relationship Between Patterns of LVH and Myocardial Ischemia Hypertension. 30: 730-734. PMID 9323014 DOI: 10.1161/01.Hyp.30.3.730 |
0.351 |
|
| 1997 |
Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H. Role of vasopressin in essential hypertension: racial differences. Journal of Hypertension. 15: 545-550. PMID 9170008 DOI: 10.1097/00004872-199715050-00011 |
0.384 |
|
| 1997 |
Manolis AJ, Olympios C, Sifaki M, Handanis S, Cokkinos D, Bresnahan M, Gavras I, Gavras H. Combined Sympathetic Suppression and Angiotensin-Converting Enzyme Inhibition in Congestive Heart Failure Hypertension. 29: 525-530. PMID 9039154 DOI: 10.1161/01.Hyp.29.1.525 |
0.356 |
|
| 1997 |
Gavras H. Result of the U.S. hypertension report card American Journal of Hypertension. 10: 240. DOI: 10.1016/S0895-7061(97)89534-9 |
0.307 |
|
| 1997 |
Gavras H. Wednesday May 28, Ballroom C, 3:30 pm Update in Hypertension and Target Organ Damage: Prevention of myocardial damage in hypertension American Journal of Hypertension. 10. DOI: 10.1016/S0895-7061(97)89522-2 |
0.319 |
|
| 1997 |
Gavras H. Mouse models of experimental hypertension American Journal of Hypertension. 10. DOI: 10.1016/S0895-7061(97)89451-4 |
0.334 |
|
| 1996 |
Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of Experimental Hypertension in Mice Hypertension. 28: 1064-1069. PMID 8952597 DOI: 10.1161/01.Hyp.28.6.1064 |
0.389 |
|
| 1996 |
Ruocco NA, Bergelson BA, Yu TK, Gavras I, Gavras H. Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykinin. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 17: 1059-72. PMID 8556004 DOI: 10.3109/10641969509033651 |
0.317 |
|
| 1995 |
Manolis AJ, Gavras I, Pieprzak M, Gavras H. Isradipine versus captopril in patients with essential hypertension. Clinical Therapeutics. 17: 648-654. PMID 8565028 DOI: 10.1016/0149-2918(95)80041-7 |
0.333 |
|
| 1995 |
Flordellis CS, Berguerand M, Gouache P, Barbu V, Gavras H, Handy DE, Béréziat G, Masliah J. Alpha 2 adrenergic receptor subtypes expressed in Chinese hamster ovary cells activate differentially mitogen-activated protein kinase by a p21ras independent pathway. Journal of Biological Chemistry. 270: 3491-3494. PMID 7876081 DOI: 10.1074/Jbc.270.8.3491 |
0.305 |
|
| 1995 |
Kohlman O, Neves FdAR, Ginoza M, Tavares A, Cezaretti ML, Zanella MT, Ribeiro AB, Gavras I, Gavras H. Role of Bradykinin in Insulin Sensitivity and Blood Pressure Regulation During Hyperinsulinemia Hypertension. 25: 1003-1007. PMID 7737706 DOI: 10.1161/01.Hyp.25.5.1003 |
0.329 |
|
| 1995 |
Manolis AJ, Olympios C, Sifaki M, Handanis S, Bresnahan M, Gavras I, Gavras H. Suppressing Sympathetic Activation in Congestive Heart Failure A New Therapeutic Strategy Hypertension. 26: 719-724. PMID 7591009 DOI: 10.1161/01.Hyp.26.5.719 |
0.365 |
|
| 1994 |
Franco R, Gut A, Ferrari-Spadotto A, Georgette J, Gavras I, Gavras H. Pressor mechanisms in adriamycin-induced nephropathy with hypertension in rats. Hypertension. 23: 246-249. PMID 8282368 DOI: 10.1161/01.Hyp.23.1_Suppl.I246 |
0.414 |
|
| 1994 |
Tobian L, Brunner HR, Cohn JN, Gavras H, Laragh JH, Materson BJ, Weber MA. Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. American Journal of Hypertension. 7: 859-872. PMID 7826548 DOI: 10.1093/Ajh/7.10.859 |
0.365 |
|
| 1993 |
De Paula RB, Plavnik FL, Rodrigues CIS, De Rocha Neves AF, Kohlmann O, Ribeiro AB, Gavras I, Gavras H. Age and race determine vasopressin participation in upright blood pressure control in essential hypertension Annals of the New York Academy of Sciences. 689: 534-536. PMID 8373040 DOI: 10.1111/J.1749-6632.1993.Tb55586.X |
0.375 |
|
| 1993 |
Handy DE, Flordellis CS, Bogdanova NN, Bresnahan MR, Gavras H. Diverse tissue expression of rat alpha 2-adrenergic receptor genes. Hypertension. 21: 861-865. PMID 7684725 DOI: 10.1161/01.Hyp.21.6.861 |
0.319 |
|
| 1992 |
Lammek B, Ito Y, Gavras I, Gavras H. Acylation of the N-Terminus of B2 Bradykinin Antagonists with Bulky Substituents Dramatically Increases Potency Collection of Czechoslovak Chemical Communications. 57: 1960-1966. DOI: 10.1135/Cccc19921960 |
0.303 |
|
| 1991 |
Flordellis CS, Handy DE, Bresnahan MR, Zannis VI, Gavras H. Cloning and expression of a rat brain α2B-adrenergic receptor Proceedings of the National Academy of Sciences of the United States of America. 88: 1019-1023. PMID 1704126 DOI: 10.1073/Pnas.88.3.1019 |
0.317 |
|
| 1991 |
Wang Y, Gavras I, Lammek B, Bresnahan M, Gavras H. Effects of bradykinin and prostaglandin inhibition on systemic and regional hemodynamics in conscious normotensive rats. Journal of Hypertension. 9: 805-812. PMID 1663981 DOI: 10.1097/00004872-199109000-00006 |
0.352 |
|
| 1991 |
Gavras H, Gavras I. Cardioprotective potential of angiotensin converting enzyme inhibitors. Journal of Hypertension. 9: 385-397. PMID 1649858 DOI: 10.1097/00004872-199105000-00001 |
0.311 |
|
| 1991 |
Gavras H. Angiotensin-Converting Enzyme Inhibitors in Hypertension and Congestive Heart Failure@@@مثبطات إنزيم محلول الأنجيوتنسين في حالات ارتفاع ضغط الدم والأزمات القلبية Journal of King Abdulaziz University-Medical Sciences. 1: 3-8. DOI: 10.4197/Med.1-1.1 |
0.363 |
|
| 1991 |
Castellano M, Handy DE, Beschi M, Wang Y, Agabiti-Rosei E, Gavras H. Gene expression of catecholaminergic receptors in the central nervous system of hypertensive rats. Journal of Hypertension. 9. DOI: 10.1097/00004872-199112000-00011 |
0.377 |
|
| 1991 |
Gavras I, Gavras H. Angiotensin converting enzyme inhibitors. Journal of Hypertension. 9: 315-324. DOI: 10.1007/978-1-59259-008-7_28 |
0.383 |
|
| 1991 |
Gavras I, Gavras H. Cardioprotective potential of angiotensin-converting enzyme inhibitors Clinical Cardiology. 14: 68-71. DOI: 10.1002/Clc.4960141811 |
0.37 |
|
| 1990 |
Gavras H. Angiotensin converting enzyme inhibition and its impact on cardiovascular disease. Circulation. 81: 381-388. PMID 2404627 DOI: 10.1161/01.Cir.81.1.381 |
0.357 |
|
| 1990 |
Mulinari RA, Gavras I, Wang YX, Franco R, Gavras H. Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction. Circulation. 81: 308-311. PMID 2404626 DOI: 10.1161/01.Cir.81.1.308 |
0.331 |
|
| 1990 |
Gavras H. Pressor systems in hypertension and congestive heart failure. Role of vasopressin. Hypertension. 16: 587-593. PMID 2228158 DOI: 10.1161/01.Hyp.16.5.587 |
0.399 |
|
| 1990 |
Bursztyn M, Bresnahan M, Gavras I, Gavras H. Effect of Aging on Vasopressin, Catecholamines, and Alpha2-Adrenergic Receptors Journal of the American Geriatrics Society. 38: 628-632. PMID 2162869 DOI: 10.1111/J.1532-5415.1990.Tb01420.X |
0.302 |
|
| 1990 |
Bresnahan MR, Flordellis CS, Vassilatis DK, Makrides SC, Zannis VI, Gavras H. High level of expression of functional human platelet α2-adrenergic receptors in a stable mouse C127 cell line Bba - Molecular Cell Research. 1052: 439-445. PMID 1972337 DOI: 10.1016/0167-4889(90)90153-5 |
0.306 |
|
| 1990 |
Bursztyn M, Gavras I, Tifft CP, Luther R, Boger R, Gavras H. Effects of a novel renin inhibitor in patients with essential hypertension. Journal of Cardiovascular Pharmacology. 15: 493-500. PMID 1691375 DOI: 10.1097/00005344-199003000-00021 |
0.375 |
|
| 1990 |
Waeber B, Niederberger M, Gavras H, Nussberger J, Brunner HR. Hemodynamic effects of a kinin antagonist. Journal of Cardiovascular Pharmacology. 15. DOI: 10.1097/00005344-199000156-00015 |
0.436 |
|
| 1989 |
Bursztyn M, Gavras I, Gavras H. Hypertension in the Aging Patient Implications for the Selection of Drug Therapy Journal of the American Geriatrics Society. 37: 814-818. PMID 2754162 DOI: 10.1111/J.1532-5415.1989.Tb02246.X |
0.406 |
|
| 1989 |
Bursztyn M, Gavras I, Tifft CP, Bauer JH, Melby JC, Gavras H. Renin inhibition with A-64662: effect on blood pressure and hormonal response in man. Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 7: S306-7. PMID 2698944 DOI: 10.1097/00004872-198900076-00149 |
0.42 |
|
| 1989 |
Bursztyn M, Gavras I, Blasucci DJ, Gavras H. Intravenous dilevalol in the treatment of severe hypertension. Journal of Cardiovascular Pharmacology. 13: 799-802. DOI: 10.1097/00005344-198905000-00017 |
0.405 |
|
| 1988 |
Vlahakos D, Gavras H. Central sympathetic stimulation produced by saline application into the nucleus tractus solitarii area of conscious rats. Neuroscience Letters. 92: 335-340. PMID 3200489 DOI: 10.1016/0304-3940(88)90613-1 |
0.371 |
|
| 1988 |
Gavras H. The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases. The New England Journal of Medicine. 319: 1541-1543. PMID 3185679 DOI: 10.1056/Nejm198812083192310 |
0.318 |
|
| 1988 |
Makrides SC, Mulinari R, Zannis VI, Gavras H. Regulation of renin gene expression in hypertensive rats Hypertension. 12: 405-410. PMID 3049341 DOI: 10.1161/01.Hyp.12.4.405 |
0.344 |
|
| 1988 |
Gavras I, Mulinari R, Gavras H. Renin-angiotensin and vasopressin in the development of salt-induced hypertension. Journal of Hypertension. 6: 999-1002. PMID 2975694 DOI: 10.1097/00004872-198812000-00007 |
0.416 |
|
| 1988 |
Mulinari RA, Gouni I, Gavras I, Gavras H. Acute effects of the new angiotensin-converting enzyme inhibitor cilazapril: a pilot study. The Journal of Clinical Pharmacology. 28: 660-663. PMID 2975290 DOI: 10.1002/J.1552-4604.1988.Tb03194.X |
0.358 |
|
| 1988 |
Gavras I, Gavras H. Role of Bradykinin in Hypertension and the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors The American Journal of the Medical Sciences. 295: 305-307. PMID 2834950 DOI: 10.1097/00000441-198804000-00015 |
0.395 |
|
| 1987 |
Benetos A, Gavras I, Gavras H. Stimulation of vasopressin by calcium microinjections in the area of the paraventricular nucleus of the hypothalamus. Brain Research. 412: 182-184. PMID 3607454 DOI: 10.1016/0006-8993(87)91458-2 |
0.327 |
|
| 1987 |
Gavras I, Mulinari R, Gavras H, Higgins JT, Reeves RL, Zawada ET, Crook J, Halperin AK, Garrett B. Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system The American Journal of Medicine. 83: 20-23. PMID 3332575 DOI: 10.1016/0002-9343(87)90632-2 |
0.351 |
|
| 1987 |
Papadoliopoulou-Diamandopoulou N, Papagalanis N, Gavras I, Gavras H. Vasopressin in End-Stage Renal Disease: Relationship to Salt, Catecholamines and Renin Activity Clinical and Experimental Hypertension. 9: 1197-1208. PMID 3304733 DOI: 10.3109/10641968709160043 |
0.337 |
|
| 1987 |
Benetos A, Bresnahan M, Gavras I, Gavras H. Central catecholamines and alpha-adrenoceptors in acute hypertension induced by intracerebroventricular hypertonic saline. Journal of Hypertension. 5: 699-704. PMID 2828469 DOI: 10.1097/00004872-198712000-00011 |
0.36 |
|
| 1986 |
Benetos A, Gavras I, Gavras H. Norepinephrine applied in the paraventricular hypothalamic nucleus stimulates vasopressin release. Brain Research. 381: 322-326. PMID 3827993 DOI: 10.1016/0006-8993(86)90083-1 |
0.358 |
|
| 1986 |
Gavras I, Hatinoglou S, Benetos A, Gavras H. Calcium stimulates vasopressin release. Journal of Hypertension. 4: 451-454. PMID 3772099 DOI: 10.1097/00004872-198608000-00009 |
0.389 |
|
| 1986 |
Benetos A, Gavras I, Gavras H. Hypertensive effect of a bradykinin antagonist in normotensive rats. Hypertension. 8: 1089-1092. PMID 3770870 DOI: 10.1161/01.Hyp.8.11.1089 |
0.45 |
|
| 1986 |
Creager MA, Faxon DP, Cutler SS, Kohlmann O, Ryan TJ, Gavras H. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. Journal of the American College of Cardiology. 7: 758-65. PMID 3514728 DOI: 10.1016/S0735-1097(86)80333-3 |
0.334 |
|
| 1986 |
Gavras I, Gavras H. Clinical utility of angiotensin converting enzyme inhibitors in hypertension The American Journal of Medicine. 81: 28-31. PMID 3022582 DOI: 10.1016/0002-9343(86)90941-1 |
0.432 |
|
| 1986 |
Strauss R, Gavras I, Vlahakos D, Gavras H. Enalaprilat in hypertensive emergencies The Journal of Clinical Pharmacology. 26: 39-43. PMID 3005376 DOI: 10.1002/J.1552-4604.1986.Tb02900.X |
0.402 |
|
| 1985 |
Gavras I, Gavras H. Nifedipine in the treatment of essential hypertension. The Journal of Clinical Pharmacology. 25: 429-432. PMID 3902911 DOI: 10.1002/J.1552-4604.1985.Tb02871.X |
0.389 |
|
| 1985 |
Gavras H, Bain GT, Bland L, Vlahakos D, Gavras I. Hypertensice response to saline microinjection in the area of the nucleus tractus solitarii of the rat Brain Research. 343: 113-119. PMID 2994826 DOI: 10.1016/0006-8993(85)91164-3 |
0.379 |
|
| 1985 |
Vlahakos D, Gavras I, Gavras H. α-Adrenoceptor agonists applied in the area of the nucleus tractus solitarii in the rat: effect of anesthesia on cardiovascular responses Brain Research. 347: 372-375. PMID 2866015 DOI: 10.1016/0006-8993(85)90202-1 |
0.374 |
|
| 1985 |
Kohlmann O, Gavras I, Biollaz J, Biollaz B, Gavras H. Sodium chloride-induced partial inhibition in vivo of alpha 2-adrenoceptor agonist function. Journal of Hypertension. 3: 269-74. PMID 2862207 DOI: 10.1097/00004872-198506000-00012 |
0.35 |
|
| 1984 |
DiPette D, Gavras I, North W, DiPette P, Gavras H. Vasopressin response to hyperosmotic stimulus: blood pressure effect in normal subjects and patients with impaired sympathetic system. Clinical and Experimental Hypertension. 6: 851-861. PMID 6723091 DOI: 10.3109/10641968409044042 |
0.346 |
|
| 1984 |
Ying CY, Tifft CP, Gavras H, Chobanian AV. Renal Revascularization in the Azotemic Hypertensive Patient Resistant to Therapy The New England Journal of Medicine. 311: 1070-1075. PMID 6237260 DOI: 10.1056/Nejm198410253111702 |
0.378 |
|
| 1984 |
Gavras I, Vlahakos D, Melby JC, Gavras H. Pilot Study of the Effects of the Angiotensin‐Converting Enzyme Inhibitor CI‐906 on Patients with Essential Hypertension The Journal of Clinical Pharmacology. 24: 343-350. PMID 6090509 DOI: 10.1002/J.1552-4604.1984.Tb02786.X |
0.4 |
|
| 1984 |
Hatzinikolaou P, Gavras H, North WG, Kohlmann O, Gavras I. Evidence for dopaminergic regulation of vasopressin release in the anephric rat. Journal of Hypertension. 2: 311-315. DOI: 10.1097/00004872-198406000-00015 |
0.347 |
|
| 1983 |
Hatzinikolaou P, Charocopos F, Gavras I, Gavras H. Systemic and regional hemodynamic effects of propranolol in intact and anephric rats. Clinical and Experimental Hypertension. 5: 729-739. PMID 6883742 DOI: 10.3109/10641968309081804 |
0.349 |
|
| 1983 |
Gavras H. Hypertension and congestive heart failure: Benefits of converting enzyme inhibition (captopril) Journal of the American College of Cardiology. 1: 518-520. PMID 6338084 DOI: 10.1016/S0735-1097(83)80082-5 |
0.329 |
|
| 1983 |
Gavras I, Gavras H. Captopril and enalapril. Annals of Internal Medicine. 98: 556-557. PMID 6301322 DOI: 10.7326/0003-4819-98-4-556_2 |
0.351 |
|
| 1982 |
Gavras H. Possible Mechanisms of Sodium-Dependent Hypertension: Volume Expansion or Vasoconstriction? Clinical and Experimental Hypertension. 4: 737-747. PMID 7105437 DOI: 10.3109/10641968209061610 |
0.386 |
|
| 1982 |
Gavras I, Gavras H, Chobanian AV, Tifft CP, Melby JC, Jick H. Hypertension and age: clinical and biochemical correlates. Clinical and Experimental Hypertension. 4: 1097-1106. PMID 6749343 DOI: 10.3109/10641968209060777 |
0.336 |
|
| 1982 |
Burner M, Biollaz J, Brunner HR, Turini GA, Gavras H. Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril. American Journal of Cardiology. 49: 1550-1551. PMID 6280484 DOI: 10.1016/0002-9149(82)90386-1 |
0.385 |
|
| 1982 |
Halperin JL, Faxon DP, Creager MA, Bass TA, Melidossian CD, Gavras H, Ryan TJ. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure American Journal of Cardiology. 50: 967-972. PMID 6182786 DOI: 10.1016/0002-9149(82)90403-9 |
0.309 |
|
| 1982 |
Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB. Insulin Infusion in Conscious Dogs: EFFECTS ON SYSTEMIC AND CORONARY HEMODYNAMICS, REGIONAL BLOOD FLOWS, AND PLASMA CATECHOLAMINES Journal of Clinical Investigation. 69: 1321-1336. PMID 6123523 DOI: 10.1172/Jci110572 |
0.309 |
|
| 1982 |
Dipette DJ, Gavras I, North WG, Brunner HR, Gavras H. Vasopressin in salt-induced hypertension of experimental renal insufficiency. Hypertension. 4: 125-130. DOI: 10.1161/01.Hyp.4.3_Pt_2.125 |
0.382 |
|
| 1982 |
Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade. Journal of Cardiovascular Pharmacology. 4: 966-972. DOI: 10.1097/00005344-198211000-00014 |
0.405 |
|
| 1982 |
Hatzinikolaou P, Gavras I, North WG, Brunner HR, Gavras H. Interaction of the Sympathetic Nervous System with Vasopressin and Renin in the Maintenance of Blood Pressure in Rats Clinical Science. 63. DOI: 10.1042/Cs063313S |
0.395 |
|
| 1982 |
Frohlich ED, Maxwell MH, Baer L, Gavras H, Hollifield JW, Krakoff LR, Lifschitz MD, Logan A, Poutasse E, Streeten DHP. Use of Saralasin as a Diagnostic Test in Hypertension: Report of a Consensus Committee Jama Internal Medicine. 142: 1437-1440. DOI: 10.1001/Archinte.1982.00340210029004 |
0.352 |
|
| 1982 |
Waeber B, Brunner HR, Burckhardt P, Gavras H. Hypertension in a Patient With Hypercalcemia: Captopril and Verapamil Jama Internal Medicine. 142: 143-145. DOI: 10.1001/Archinte.1982.00340140145024 |
0.415 |
|
| 1981 |
Gavras H, Waeber B, Kershaw GR, Liang CS, Textor SC, Brunner HR, Tifft CP, Gavras I. Role of reactive hyperreninemia in blood pressure changes induced by sodium depletion in patients with refractory hypertension. Hypertension. 3: 441-447. PMID 7030951 DOI: 10.1161/01.Hyp.3.4.441 |
0.415 |
|
| 1981 |
Gavras H, Brunner HR, Gavras I. Captopril in the Treatment of Hypertension Annals of Internal Medicine. 95: 505-506. PMID 7025722 DOI: 10.7326/0003-4819-95-4-505 |
0.33 |
|
| 1981 |
Textor SC, Gavras H, Tifft CP, Bernard DB, Idelson B, Brunner HR. Norepinephrine and renin activity in chronic renal failure. Evidence for interacting roles in hemodialysis hypertension. Hypertension. 3: 294-299. PMID 7019067 DOI: 10.1161/01.Hyp.3.3.294 |
0.383 |
|
| 1981 |
Gavras I, Gavras H, Tifft CP, Kershaw GR, Bresnahan M. Effect of Pindolol on Blood Pressure, Plasma Renin Activity, and Catecholamines in Hypertensive Patients The Journal of Clinical Pharmacology. 21: 79-83. PMID 7014658 DOI: 10.1002/J.1552-4604.1981.Tb01753.X |
0.401 |
|
| 1981 |
Gavras I, Graff LG, Rose BD, McKENNA JM, Brunner HR, Gavras H. Fatal Pancytopenia Associated with the Use of Captopril Annals of Internal Medicine. 94: 58-59. PMID 7004300 DOI: 10.7326/0003-4819-94-1-58 |
0.359 |
|
| 1981 |
Textor SC, Brunner HR, Gavras H. Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism. Hypertension. 3: 269-276. PMID 6260647 DOI: 10.1161/01.Hyp.3.2.269 |
0.422 |
|
| 1981 |
Hatzinikolaou P, Gavras H, Waeber B, Fisher GH, Ryan JW. Comparative study of three parenteral inhibitors of the angiotensin converting enzyme Biochemical Pharmacology. 30: 1869-1872. PMID 6168270 DOI: 10.1016/0006-2952(81)90029-0 |
0.316 |
|
| 1981 |
Gavras H, Waeber B, Gavras I, Biollaz J, Brunner H, Davies R. Antihypertensive Effect Of The New Oral Angiotensin Converting Enzyme Inhibitor "Mk-421". The Lancet. 318: 543-547. PMID 6116000 DOI: 10.1016/S0140-6736(81)90937-5 |
0.345 |
|
| 1980 |
Hatzinikolaou P, Gavras H, Brunner HR, Gavras I. Sodium-induced elevation of blood pressure in the anephric state. Science. 209: 935-936. PMID 7403861 DOI: 10.1126/Science.7403861 |
0.386 |
|
| 1980 |
Textor SC, Brunner HR, Gavras H. Converting enzyme inhibition during chronic angiotensin II infusion in rats: Evidence against a non-angiotensin mechanism Clinical Science. 59. PMID 6256120 DOI: 10.1042/Cs059071S |
0.399 |
|
| 1980 |
Waeber B, Brunner HR, Brunner DB, Curtet AL, Turini GA, Gavras H. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril. Hypertension. 2: 236-42. PMID 6247269 DOI: 10.1161/01.Hyp.2.2.236 |
0.409 |
|
| 1979 |
Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. The New England Journal of Medicine. 301: 68-73. PMID 449947 DOI: 10.1056/Nejm197907123010202 |
0.426 |
|
| 1979 |
Tifft CP, Gavras H, Kershaw GR, Gavras I, Brunner HR, Liang C, Chobanian AV. Converting Enzyme Inhibition in Hypertensive Emergencies Annals of Internal Medicine. 90: 43-47. PMID 420460 DOI: 10.7326/0003-4819-90-1-43 |
0.405 |
|
| 1979 |
Brunner HR, Gavras H, Waeber B, Turini GA, McKinstry DN, Vukovich RA, Gavras I. Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension. British Journal of Clinical Pharmacology. 7. PMID 223614 DOI: 10.1111/J.1365-2125.1979.Tb04692.X |
0.376 |
|
| 1979 |
Brunner HR, Gavras H, Waeber B, Kershaw GR, Turini GA, Vukovich RA, McKINSTRY DN, Gavras I. Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients Annals of Internal Medicine. 90: 19-23. PMID 217289 DOI: 10.7326/0003-4819-90-1-19 |
0.373 |
|
| 1979 |
Volicer L, O'Donnell A, Chase A, Gavras H. Cyclic nucleotide levels in brains of control and hypertensive rats. Life Sciences. 24: 131-5. PMID 216871 DOI: 10.1016/0024-3205(79)90122-X |
0.302 |
|
| 1979 |
Turini G, Brunner H, Gribic M, Waeber B, Gavras H. Improvement Of Chronic Congestive Heart-Failure By Oral Captopril The Lancet. 313: 1213-1215. PMID 87679 DOI: 10.1016/S0140-6736(79)91897-X |
0.351 |
|
| 1978 |
Liang C, Gavras H. Renin-Angiotensin System Inhibition in Conscious Dogs during Acute Hypoxemia: EFFECTS ON SYSTEMIC HEMODYNAMICS, REGIONAL BLOOD FLOWS, AND TISSUE METABOLISM Journal of Clinical Investigation. 62: 961-970. PMID 711860 DOI: 10.1172/Jci109225 |
0.347 |
|
| 1978 |
Turini GA, Brunner HR, Ferguson RK, Rivier JL, Gavras H. Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade. Heart. 40: 1134-1142. PMID 708515 DOI: 10.1136/Hrt.40.10.1134 |
0.4 |
|
| 1978 |
Chobanian AV, Gavras H, Gavras I, Bresnahan M, Sullivan P, Melby JC. Studies on the activity of the sympathetic nervous system in essential hypertension. Journal of Human Stress. 4: 22-28. PMID 690418 DOI: 10.1080/0097840X.1978.9934992 |
0.375 |
|
| 1978 |
Liang C, Gavras H, Hood WB. Renin-Angiotensin System Inhibition in Conscious Sodium-Depleted Dogs: EFFECTS ON SYSTEMIC AND CORONARY HEMODYNAMICS Journal of Clinical Investigation. 61: 874-883. PMID 659580 DOI: 10.1172/Jci109013 |
0.38 |
|
| 1978 |
Jaeger P, Ferguson RK, Brunner HR, Kirchertz EJ, Gavras H. Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats Kidney International. 13: 289-296. PMID 651128 DOI: 10.1038/Ki.1978.42 |
0.356 |
|
| 1978 |
Jaeger P, Ferguson RK, Brunner HR, Turini GA, Gavras H. Relationships of renin and aldosterone to antihypertensive effects of spironolactone and propranolol. The Journal of Clinical Pharmacology. 18: 311-318. PMID 353088 DOI: 10.1002/J.1552-4604.1978.Tb01599.X |
0.32 |
|
| 1978 |
Chobanian AV, Gavras H, Melby JC, Gavras I, Jick H. Relationship of basal plasma noradrenaline to blood pressure, age, sex, plasma renin activity and plasma volume in essential hypertension. Clinical Science. 55. PMID 282107 DOI: 10.1042/Cs055093S |
0.361 |
|
| 1978 |
Liang C, Gavras H, Brunner HR. Redistribution of regional blood flow after administration of saralasin in salt-depleted dogs. Clinical Science. 55. PMID 282061 DOI: 10.1042/Cs055243S |
0.388 |
|
| 1978 |
Gavras H, Gavras I, Textor S, Volicer L, Brunner HR, Rucinska EJ. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension. The Journal of Clinical Endocrinology and Metabolism. 46: 220-6. PMID 220274 DOI: 10.1210/Jcem-46-2-220 |
0.401 |
|
| 1978 |
Brecher P, Tercyak A, Gavras H, Chobanian AV. Peptidyl dipeptidase in rabbit brain microvessels Bba - Enzymology. 526: 537-546. PMID 214128 DOI: 10.1016/0005-2744(78)90144-4 |
0.32 |
|
| 1978 |
Gavras H, Brunner HR, Turini GA, Kershaw GR, Tifft CP, Cuttelod S, Gavras I, Vukovich RA, McKinstry DN. Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor Sq 14225 in Man The New England Journal of Medicine. 298: 991-995. PMID 205788 DOI: 10.1056/Nejm197805042981803 |
0.397 |
|
| 1978 |
Brunner H, Wauters J, Mckinstry D, Waeber B, Gustave-Turini, Gavras H. Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure. The Lancet. 312: 704-707. PMID 80634 DOI: 10.1016/S0140-6736(78)92703-4 |
0.426 |
|
| 1977 |
Posternak L, Brunner HR, Gavras H, Brunner DB. Angiotensin II blockade in normal man: interaction of renin and sodium in maintaining blood pressure. Kidney International. 11: 197-203. PMID 846071 DOI: 10.1038/Ki.1977.28 |
0.382 |
|
| 1977 |
Ferguson R, Brunner H, Turini G, Gavras H, Mckinstry D. A Specific Orally Active Inhibitor Of Angiotensin-Converting Enzyme In Man The Lancet. 309: 775-778. PMID 66571 DOI: 10.1016/S0140-6736(77)92958-0 |
0.336 |
|
| 1977 |
Gavras H, Flessas A, Ryan TJ, Brunner HR, Faxon DP, Gavras I. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension. Jama. 238: 880-882. DOI: 10.1001/Jama.1977.03280090044020 |
0.354 |
|
| 1977 |
Gavras H, Gavras I, Cannon PJ, Brunner HR, Laragh JH. Is Elevated Plasma Renin Activity of Prognostic Importance in Progressive Systemic Sclerosis Jama Internal Medicine. 137: 1554-1558. DOI: 10.1001/Archinte.1977.03630230044013 |
0.362 |
|
| 1976 |
Gavras H, Ribeiro A, Brunner HR, Gavras I. Determination of renin-dependency and sodium-dependency in the three renin sub-groups of essential hypertension. Clinical Science. 3. PMID 1071607 DOI: 10.1042/Cs051197S |
0.38 |
|
| 1976 |
Brunner HR, Gavras H. Pathophysiological concepts of renovascular hypertension. Contributions to Nephrology. 3: 20-29. PMID 1026366 DOI: 10.1159/000399377 |
0.378 |
|
| 1976 |
Gavras H, Ribeiro AB, Gavras I, Brunner HR. Reciprocal relation between renin dependency and sodium dependency in essential hypertension. The New England Journal of Medicine. 295: 1278-1283. PMID 980059 DOI: 10.1056/Nejm197612022952302 |
0.438 |
|
| 1975 |
Gavras H, Brunner H, Thurston H, Laragh J. Reciprocation of renin dependency with sodium volume dependency in renal hypertension. Science. 188: 1316-1317. PMID 1145199 DOI: 10.1126/Science.1145199 |
0.439 |
|
| 1975 |
Laragh JH, Sealey JE, Bühler FR, Vaughan ED, Brunner HR, Gavras H, Baer L. The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension The American Journal of Medicine. 58: 4-13. PMID 234677 DOI: 10.1016/0002-9343(75)90527-6 |
0.392 |
|
| 1975 |
Brunner HR, Gavras H. Vascular Damage in Hypertension Hospital Practice. 10: 97-108. DOI: 10.1080/21548331.1975.11946411 |
0.336 |
|
| 1975 |
Brunner HR, Gavras H. Clinical Implications of Renin in the Hypertensive Patient Jama. 233: 1091-1093. DOI: 10.1001/Jama.1975.03260100061025 |
0.434 |
|
| 1974 |
Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, Vukovich RA. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. The New England Journal of Medicine. 291: 817-821. PMID 4371298 DOI: 10.1056/Nejm197410172911603 |
0.436 |
|
| 1974 |
Gavras H, Brunner H, Gavras I, Laragh J. Hypotensive Effect Of Angiotensin-Converting-Enzyme Inhibitor Sq 20,881 The Lancet. 304: 353. PMID 4136088 DOI: 10.1016/S0140-6736(74)91734-6 |
0.328 |
|
| 1971 |
Gavras H, Brown WCB, Brown JJ, Lever AF, Linton AL, Macadam RF, Mcnicol GP, Robertson JIS, Wardrop C. Microangiopathic Hemolytic Anemia and the Development of the Malignant Phase of Hypertension Circulation Research. 28. PMID 5568228 DOI: 10.1161/01.Res.28.5.Ii-127 |
0.404 |
|
| Show low-probability matches. |